2024 November Author Interview-Ryan Law and Juan Carlos Bucobo
Drs Ryan Law and Juan Carlos Bucobo discuss their Technology Status Evaluation Report, “Submucosal injection fluid and tattoo agents” from the November issue…
Drs Ryan Law and Juan Carlos Bucobo discuss their Technology Status Evaluation Report, “Submucosal injection fluid and tattoo agents” from the November issue…
Join us at HTTR 2024 in Washington, DC, USA, for dynamic sessions that provide a comprehensive look at the molecular mechanisms that drive resistance to…
PHILADELPHIA — Pharmacologic therapy for alcohol use disorder may be an “underutilized treatment modality,” especially in patients with related liver disease, according to research presented…
The Excellence in Clinical Endocrinology Leadership (ExCEL) program is now accepting applications. Individuals from diverse backgrounds and underrepresented …
The FDA issued a complete response letter to Intercept Pharmaceuticals indicating it cannot grant full approval to the company’s supplemental new drug application for Ocaliva…
Prior antibiotic use may be a factor in the rising incidence of colorectal cancer seen in those under 50 years of age (early-onset colorectal cancer…
Join Drs Feyma and Armstrong for a LIVE discussion about how to refer a patient suspected of having Rett syndrome (RTT) to specialty care and…
Subscribe to The VPZD Show on your favorite podcast platform here: https://link.chtbl.com/vpzdVinay Prasad, MD MPH; Physician & Professor Hematologist/ Oncol…
To cite: Singal AG, Narasimman M, Daher D, et al. Effectiveness of mailed outreach and patient navigation to promote HCC screening process completion: a mult…
Could you count on your fingers the number of corpses you’ve seen, touched, kissed, or embraced? Death Thought Leader Kevin Toolis challenges us to look…
Background The impact of nucleos(t)ide analogues on intrahepatic viral burden and immune microenvironment in patients with chronic hepatitis B (CHB) is not clear. Objective We…